The Centre on Saturday asserted that adequate funds were available during the2012-13 financial year to meet job demands by below poverty line (BPL) households under the Mahatma Gandhi NREGS. Union Minister of Rural Development Jairam Ramesh underlined that he has recommended reallocation of funds for rural development, especially fordrinking water and sanitation projects, to ensure inclusive growth and reflect the percolation of the high growth rate to the rural side. At the...

-The Hindu The budget focuses on rural development with a moderate hike in allocation, but the government has downsized in a big way the importance of its flagship programme, the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA), on which it reportedly galloped to power in 2009. For the scheme entitling jobs to below poverty line (BPL) households in rural areas, the allocation has been reduced by 17.5 per cent to only...

Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...

-The Times of India Instead of creating happiness in the lives of farmers in adjacent villages, Adani power corporation has rendered them landless as their agricultural land is forcibly acquired by the district administration for requirement of the thermal power company. Once affluent, these farmers have now come below poverty line. Adani Thermal Power Corporation has acquired agricultural land in and around it's thermal power plant near Tiroda (Gondia). The state government gave...

-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...